On March 14, 2018, Thermo Fisher Scientific (TMO) closed at $213.46 per share. TMO stock was trading at its 52-week high of $226.44 on February 1, 2018, following the company’s strong 4Q17 earnings release on January 31, 2018. Yet again, the results exceeded Wall Street estimates. TMO stock registered a rise of ~3.5%.
TMO stock registered its 52-week low share price of $151.74 on April 12, 2017. The stock has registered a strong stock rally over the past one year. The 12-month TMO stock return stands at a stellar 34%. It’s currently trading higher than its 50-day moving average of $211.48 per share as well as its 200-day moving average of $197.62.
Year-to-date (or YTD), Thermo Fisher Scientific has registered a rise of ~12.4% in its stock price. After a gradual rise in prices over the last one year with certain events triggering a decline in the company’s stock price in December 2017, starting in 2018, the company’s stock has performed very well. Over the past six months, the stock has shown a stock return of ~11.4%.
On March 14, 2018, Thermo Fisher Scientific’s peers Illumina (ILMN), Abbott Laboratories (ABT), and Agilent Technologies (A) reported 12-month stock price returns of approximately 50.6%, 37.5%, and 34%, respectively.
The US medical device industry, which can be represented by the iShares US Medical Devices ETF (IHI), registered a one-year stock price rise of ~26% as of March 14, 2018. Thus, TMO stock provided better one-year investment returns than the sector average. The S&P 500 Index has registered a one-year gain of ~16% as of March 14, 2018.